CN105079394A - Pharmaceutic preparation for treating arrhythmia - Google Patents

Pharmaceutic preparation for treating arrhythmia Download PDF

Info

Publication number
CN105079394A
CN105079394A CN201510604679.XA CN201510604679A CN105079394A CN 105079394 A CN105079394 A CN 105079394A CN 201510604679 A CN201510604679 A CN 201510604679A CN 105079394 A CN105079394 A CN 105079394A
Authority
CN
China
Prior art keywords
parts
treatment
radix
pharmaceutical preparation
herba
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510604679.XA
Other languages
Chinese (zh)
Inventor
孙本如
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quanjiao Xianqi Pharmaceutical Technology Co Ltd
Original Assignee
Quanjiao Xianqi Pharmaceutical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quanjiao Xianqi Pharmaceutical Technology Co Ltd filed Critical Quanjiao Xianqi Pharmaceutical Technology Co Ltd
Priority to CN201510604679.XA priority Critical patent/CN105079394A/en
Publication of CN105079394A publication Critical patent/CN105079394A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention belongs to the field of Chinese herbal preparations, and in particular relates to a pharmaceutic preparation for treating arrhythmia. The pharmaceutic preparation is prepared from the following raw materials in parts by weight: 22 parts of microsorium fortunei ching, 18 parts of nicandra physalodes, 21 parts of all-grass of vigleaf stonecrop, 17 parts of Swertia bimaculata (Sieb. et Zucc.) Hook. f. et Thoms., 25 parts of poria with hostwood, 28 parts of astragalus membranaceus, 25 parts of the root of red-rooted salvia, 15 parts of angelica sinensis, 20 parts of pseudo-ginseng, 25 parts of semen plantaginis, 20 parts of Chinese yam, 25 parts of dandelion, 15 parts of chrysanthemum flowers, 15 parts of schisandra chinensis, 15 parts of rhizoma acori graminei, 15 parts of ligusticum wallichii, and 5 parts of liquorice. The pharmaceutic preparation can treat arrhythmia.

Description

One is used for the treatment of ARR pharmaceutical preparation
Technical field
The present invention relates to technical field of traditional Chinese medicine preparation, be specifically related to one and be used for the treatment of ARR pharmaceutical preparation and its preparation method and application.
Background technology
Arrhythmia is because the exciting exception of sinuatrial node or excitement result from beyond sinuatrial node; exciting conduction slowly, retardance or through abnormal passage conduction, namely the origin of cardiomotility and (or) conductive impairment cause frequency and (or) the allorhythmia of heartbeat.Arrhythmia is one group of disease important in cardiovascular disease.It can be fallen ill separately and also can occur together with cardiovascular diseases.Can break out and cause sudden death, also sustainablely involve heart and cause its exhaustion.For this reason, be bursting to develop and manyly treat the needs that ARR medicine meets clinical treatment safely and effectively.
Summary of the invention
In order to solve the problem, the object of the present invention is to provide a kind of Chinese medicine preparation for the treatment of arrhythmia disease.In order to reach this object, adopt following technical scheme:
Technical scheme: one is used for the treatment of ARR pharmaceutical preparation, the active component contained by it is extracted by following raw materials in part by weight medicine and is prepared from: Microsorium fortunei (Moore) Ching [Drynaria fortunei Moore 22 parts, large thousand raw 18 parts, Herba Sebi drymarioidiss 21 parts, greatly Herba vallisneriae Spiralis 17 parts, Poria cum Radix Pini 25 parts, the Radix Astragali 28 parts, Radix Salviae Miltiorrhizae 25 parts, Radix Angelicae Sinensis 15 parts, Radix Notoginseng 20 parts, Semen Plantaginis 25 parts, Rhizoma Dioscoreae 20 parts, Herba Taraxaci 25 parts, Flos Chrysanthemi 20 parts, Fructus Schisandrae Chinensis 15 parts, Rhizoma Acori Graminei 15 parts, Rhizoma Chuanxiong 15 parts, 5 parts, Radix Glycyrrhizae.
Describedly be used for the treatment of ARR pharmaceutical preparation, dosage form is pharmaceutically acceptable granule, tablet, capsule.
Describedly be used for the treatment of ARR pharmaceutical preparation, preparation process is: get above-mentioned Chinese medicine, add the water of medical material 10 times of weight, soak 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, merge twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adding ethanol makes the percent by volume of alcohol content reach 75%, stir, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, leaving air temp is 90 DEG C, temperature of charge is 70 DEG C, atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, add adjuvant and make capsule, tablet, granule.
Described be used for the treatment of ARR pharmaceutical preparation preparation treatment arrhythmic agent in application.
Microsorium fortunei (Moore) Ching [Drynaria fortunei Moore is Polypodiaceae subfam. Microsoroideae Cyclosorus plant south of the River Microsorium Link Microsoriumfortune (Moore) Ching, is used as medicine with herb and root stock.The four seasons can adopt, and clean, using fresh herb or dry.Clearing away heat-damp and promoting diuresis, cooling blood for hemostasis, reducing swelling and alleviating pain.For jaundice, dysentery, urinary tract infection, tuberculous lymphadenitis, leucorrhea, rheumatic arthritis, hemoptysis, spits blood, has blood in stool, epistaxis; Traumatic injury is controlled in external, fracture, venom, furuncle swelling toxin.The present invention is with all herbal medicine.
Large thousand raw Classification system Nicandraphysaloides, calm, eliminate the phlegm, heat-clearing and toxic substances removing.For rabies, psychosis, epilepsy, rheumatic arthritis, nasal sinusitis, flu, urinary tract infection, furuncle.The present invention is used as medicine with root.
Herba Sebi drymarioidis is the herb of crassulaceae plants great Ye flame grass.Clearing away heat and cooling blood, subduing swelling and detoxicating.Control haematemesis, hemoptysis.
Large Herba vallisneriae Spiralis is Gentianaceae Swertia plant two point Herba Swertiae bimaculatae Swertiabimaculata (Sieb.etZucc.) Hook.f.etThoms., with all herbal medicine.Xia Qiucai herb, dries.Heat-clearing and toxic substances removing, 'Shugan Lidan '.For acute, chronic hepatitis, cholecystitis, urinary tract infection, gastroenteritis, cold, fever, influenza, pharyngolaryngitis, toothache.All the other Chinese medicines are pharmacopeia kind.
Beneficial effect: the traditional Chinese medical science is thought, arrhythmia belongs to the category such as the traditional Chinese medical science " cardiopalmus ", " palpitation with a distress feeling ", " thoracic obstruction ", " pained ", how because internal organs negative and positive of qi and blood is deficient, internal damage by the excessive seven emotions, qi depression to blood stasis reciprocal action cause become homeless foster, heart arteries and veins of the heart and lose smooth and cause.Microsorium fortunei (Moore) Ching [Drynaria fortunei Moore of the present invention, large thousand lifes, Herba Sebi drymarioidis, large Herba vallisneriae Spiralis, Poria cum Radix Pini, the Radix Astragali, Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, Radix Notoginseng heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, benefiting qi and nourishing blood are monarch drug, Semen Plantaginis, Rhizoma Dioscoreae, Herba Taraxaci, Flos Chrysanthemi, Fructus Schisandrae Chinensis, Rhizoma Acori Graminei, Rhizoma Chuanxiong vital energy regualting and blood circulation-promoting, promote blood circulation and calm the nerves as ministerial drug, Radix Glycyrrhizae is adjuvant, the mutual compatibility of full side, treatment arrhythmia successful.
Detailed description of the invention
Form by the following examples, foregoing of the present invention is described in further detail again, but this should be interpreted as that the scope of the above-mentioned theme of the present invention is only limitted to following example, all technology realized based on foregoing of the present invention all belong to scope of the present invention.
1, the preparation of granule embodiment: get Microsorium fortunei (Moore) Ching [Drynaria fortunei Moore 22g, large thousand raw 18g, Herba Sebi drymarioidis 21g, large Herba vallisneriae Spiralis 17g, Poria cum Radix Pini 25g, Radix Astragali 28g, Radix Salviae Miltiorrhizae 25g, Radix Angelicae Sinensis 15g, Radix Notoginseng 20g, Semen Plantaginis 25g, Rhizoma Dioscoreae 20g, Herba Taraxaci 25g, Flos Chrysanthemi 20g, Fructus Schisandrae Chinensis 15g, Rhizoma Acori Graminei 15g, Rhizoma Chuanxiong 15g, Radix Glycyrrhizae 5g, adds the water of medical material 10 times of weight, soaks 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, and merges twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adds ethanol and makes the percent by volume of alcohol content reach 75%, stirs, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, leaving air temp is 90 DEG C, and temperature of charge is 70 DEG C, and atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, add starch 50g, granulate, make granule.
2, the preparation of Tablets Example: get Microsorium fortunei (Moore) Ching [Drynaria fortunei Moore 22g, large thousand raw 18g, Herba Sebi drymarioidis 21g, large Herba vallisneriae Spiralis 17g, Poria cum Radix Pini 25g, Radix Astragali 28g, Radix Salviae Miltiorrhizae 25g, Radix Angelicae Sinensis 15g, Radix Notoginseng 20g, Semen Plantaginis 25g, Rhizoma Dioscoreae 20g, Herba Taraxaci 25g, Flos Chrysanthemi 20g, Fructus Schisandrae Chinensis 15g, Rhizoma Acori Graminei 15g, Rhizoma Chuanxiong 15g, Radix Glycyrrhizae 5g, adds the water of medical material 10 times of weight, soaks 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, and merges twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adds ethanol and makes the percent by volume of alcohol content reach 75%, stirs, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, and leaving air temp is 90 DEG C, and temperature of charge is 70 DEG C, atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, adds dextrin 50g, granulates, tabletting, makes tablet.
3, the preparation of capsule embodiment: get Microsorium fortunei (Moore) Ching [Drynaria fortunei Moore 22g, large thousand raw 18g, Herba Sebi drymarioidis 21g, large Herba vallisneriae Spiralis 17g, Poria cum Radix Pini 25g, Radix Astragali 28g, Radix Salviae Miltiorrhizae 25g, Radix Angelicae Sinensis 15g, Radix Notoginseng 20g, Semen Plantaginis 25g, Rhizoma Dioscoreae 20g, Herba Taraxaci 25g, Flos Chrysanthemi 20g, Fructus Schisandrae Chinensis 15g, Rhizoma Acori Graminei 15g, Rhizoma Chuanxiong 15g, Radix Glycyrrhizae 5g, adds the water of medical material 10 times of weight, soaks 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, and merges twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adds ethanol and makes the percent by volume of alcohol content reach 75%, stirs, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, and leaving air temp is 90 DEG C, and temperature of charge is 70 DEG C, atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, adds starch 50g, granulates, fill, makes capsule.
4, pharmaceutical preparation treatment arrhythmia of the present invention clinical research
Case selection: diagnostic criteria: 1. sinus P ripple, I, II, aVF, V3-V6 be upright, aVR is inverted.2. during air-breathing, sinus rate is accelerated, and during expiration, sinus rate slows down, P-P cycle difference >=120 millisecond, and heart rate speed generating period becomes.The ARR phenomenon of the recording ecg that temporarily ceases breathing disappears.3. average sinus rhythm is between 60-100pm, for normal sinus rhythm is uneven; Heart rate is at more than 100pm, and for sinus tachycardia, companion is uneven; Heart rate <60pm, for sinus bradycardia, companion is uneven.
As the ARR medicine for the treatment of, select the routine clinical observation of arrhythmia patient 40 of making a definite diagnosis, patient is divided into treatment group and matched group two groups at random, treatment group 20 example, each half of men and women, 42 ~ 65 years old age, 53.7 years old mean age, the course of disease 1 ~ 2 year; Matched group 20 example, each half of men and women, 53 ~ 66 years old age, 57.3 years old mean age, the course of disease 1 ~ 2 year; The course of disease, the degrees of symptoms for the treatment of group and matched group two groups of cases are basically identical, without significant difference, have comparability.
Medicament selection: the preparation method that treatment group takes above-mentioned granule embodiment prepares medicine of the present invention, oral, every day 2 times, each 1 time sooner or later, each 10g, after meal warm water delivery service; Within 12 days, be 1 course for the treatment of, 2 ~ 4 courses for the treatment of can fully recover, and the person of being in a bad way follows the doctor's advice the meal with wine amount of adding.
Matched group takes Diclofenac Potassium Capsules, oral, bfore meals.Adult: 100 ~ 150mg (4 ~ 6) on the one; Patients whose symptoms were less severe 75 ~ 100mg (3 ~ 4) on the one, divides and takes for 2 ~ 3 times.
Efficacy determination: (1) cures: clinical symptoms all disappears, lab testing is normal, and electrocardiogram recovers normal.(2) effective: clinical symptoms obviously alleviates, lab testing obviously improves, and electrocardiogram takes a turn for the better.(3) effective: clinical symptoms alleviates to some extent, and lab testing makes moderate progress, electrocardiogram takes a turn for the better.(4) invalid: by treating rear above-mentioned symptom without alleviating or increasing the weight of.Therapeutic effect: in table 1.
Table 1 liang group comparitive study
Group n Cure Effective Effectively Invalid Total effective rate (%)
Treatment group 20 4 12 2 2 90
Blank group 20 3 4 5 8 60
Visible the present invention has good therapeutic effect to arrhythmia, and toxic and side effects does not occur treatments period.

Claims (4)

1. one kind is used for the treatment of ARR pharmaceutical preparation, it is characterized in that, the active component contained by it is extracted by following raw materials in part by weight medicine and is prepared from: Microsorium fortunei (Moore) Ching [Drynaria fortunei Moore 22 parts, large thousand raw 18 parts, Herba Sebi drymarioidiss 21 parts, greatly Herba vallisneriae Spiralis 17 parts, Poria cum Radix Pini 25 parts, the Radix Astragali 28 parts, Radix Salviae Miltiorrhizae 25 parts, Radix Angelicae Sinensis 15 parts, Radix Notoginseng 20 parts, Semen Plantaginis 25 parts, Rhizoma Dioscoreae 20 parts, Herba Taraxaci 25 parts, Flos Chrysanthemi 20 parts, Fructus Schisandrae Chinensis 15 parts, Rhizoma Acori Graminei 15 parts, Rhizoma Chuanxiong 15 parts, 5 parts, Radix Glycyrrhizae.
2. be used for the treatment of ARR pharmaceutical preparation as claimed in claim 1, it is characterized in that, dosage form is pharmaceutically acceptable granule, tablet, capsule.
3. be used for the treatment of ARR pharmaceutical preparation as claimed in claim 1, it is characterized in that, preparation process is: get above-mentioned Chinese medicine, add the water of medical material 10 times of weight, soak 0.5h, decoct 1 hour, filter, medicinal residues add the water of medical material 8 times of weight again, decoct 1 hour, medicinal liquid leaches, merge twice decoction liquor, being evaporated to 60 DEG C of relative densities is 1.05, adding ethanol makes the percent by volume of alcohol content reach 75%, stir, leave standstill, filter, during filtrate reduced in volume to 65 DEG C, relative density is 1.25, and reclaim ethanol, obtain concentrated solution, by concentrated solution spraying dry, spray drying condition is: inlet temperature is 100 DEG C, leaving air temp is 90 DEG C, temperature of charge is 70 DEG C, atomizing pressure is 0.2 MPa, spray velocity is 10ml/s, add adjuvant and make capsule, tablet, granule.
4. be used for the treatment of the application of ARR pharmaceutical preparation in treatment arrhythmic agent according to claim 1.
CN201510604679.XA 2015-09-18 2015-09-18 Pharmaceutic preparation for treating arrhythmia Pending CN105079394A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510604679.XA CN105079394A (en) 2015-09-18 2015-09-18 Pharmaceutic preparation for treating arrhythmia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510604679.XA CN105079394A (en) 2015-09-18 2015-09-18 Pharmaceutic preparation for treating arrhythmia

Publications (1)

Publication Number Publication Date
CN105079394A true CN105079394A (en) 2015-11-25

Family

ID=54561319

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510604679.XA Pending CN105079394A (en) 2015-09-18 2015-09-18 Pharmaceutic preparation for treating arrhythmia

Country Status (1)

Country Link
CN (1) CN105079394A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105412844A (en) * 2016-01-08 2016-03-23 青岛辰达生物科技有限公司 Pharmaceutic preparation for preventing and treating arrhythmia and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103272176A (en) * 2013-05-28 2013-09-04 刘金军 Traditional Chinese medicine composition for treating cardiovascular disease and preparation method thereof
CN103735826A (en) * 2013-12-26 2014-04-23 韩明辉 Chinese herbal medicine formula for treating arrhythmia and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103272176A (en) * 2013-05-28 2013-09-04 刘金军 Traditional Chinese medicine composition for treating cardiovascular disease and preparation method thereof
CN103735826A (en) * 2013-12-26 2014-04-23 韩明辉 Chinese herbal medicine formula for treating arrhythmia and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
朱志义: "顾双林治疗病毒性心肌炎心律失常经验", 《江西中医药》 *
赵国东等: "《新编家庭中医疗法大全》", 31 January 2014, 湖北科学技术出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105412844A (en) * 2016-01-08 2016-03-23 青岛辰达生物科技有限公司 Pharmaceutic preparation for preventing and treating arrhythmia and application thereof

Similar Documents

Publication Publication Date Title
CN102772748B (en) Traditional Chinese medicine preparation for treating liver-depression qi-stagnation type viral myocarditis and preparation method thereof
CN101721608B (en) Chinese herbal medicine pill used for treating heart diseases
CN105106627A (en) Medicinal preparation for treating diabetes
CN105126034A (en) Pharmaceutical preparation for treating coronary heart disease
CN105079394A (en) Pharmaceutic preparation for treating arrhythmia
CN104857393A (en) Pharmaceutical preparation for treating arrhythmia
CN105343688A (en) Medicine composition for treating myocardial infarction and application thereof
CN105664053A (en) Traditional Chinese medicine composition for treating calluses on puncture of internal arteriovenous fistula of maintenance hemodialysis patient
CN104840703A (en) Medicine preparation for treating breast cancer
CN101579509B (en) Traditional Chinese medicine preparation for treating premature beat of cardiac rhythm
CN102755517A (en) Traditional Chinese medicine plaster for treating arrhythmia and preparation methods thereof
CN105288285A (en) Medicinal preparation for treating chronic bronchitis
CN102755580B (en) Method for preparing chewable tablets of drug for treating unstable angina pectoris
CN105250931A (en) Pharmaceutic preparation for treating stenocardia
CN105106540A (en) Medicinal preparation for treating cerebral thrombosis
CN104800497A (en) Traditional Chinese medicine composition for treating irregular menstruation of gynecology
CN105079674A (en) Medicinal preparation for treating chest stuffiness and pains
CN104873943A (en) Pharmaceutic preparation for treating anxiety
CN105267400A (en) Medicine preparation for treating gynecological vaginitis
CN105148074A (en) Medicinal preparation used for treating diabetes
CN105055845A (en) Medicine preparation for treating cardiac insufficiency
CN105106764A (en) Medicinal preparation for treating vomitus gravidarum
CN104667203A (en) Medicine for treating coronary heart disease
CN103463575B (en) Traditional Chinese medicine for treating heart-spleen-deficiency type arrhythmia and preparation method thereof
CN105412582A (en) Traditional Chinese medicine composition for treating abnormal menstruation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20151125

WD01 Invention patent application deemed withdrawn after publication